• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

选择性BH3模拟物抑制MCL-1会破坏线粒体动力学,导致人类心肌细胞活力和功能丧失。

MCL-1 Inhibition by Selective BH3 Mimetics Disrupts Mitochondrial Dynamics Causing Loss of Viability and Functionality of Human Cardiomyocytes.

作者信息

Rasmussen Megan L, Taneja Nilay, Neininger Abigail C, Wang Lili, Robertson Gabriella L, Riffle Stellan N, Shi Linzheng, Knollmann Bjorn C, Burnette Dylan T, Gama Vivian

机构信息

Department of Cell & Developmental Biology, Vanderbilt University, Nashville, TN 37232, USA.

Vanderbilt University Medical Center, Nashville, TN 37232, USA; Vanderbilt Center for Arrhythmia Research and Therapeutics, Department of Medicine, Nashville, TN 37232, USA.

出版信息

iScience. 2020 Apr 24;23(4):101015. doi: 10.1016/j.isci.2020.101015. Epub 2020 Mar 30.

DOI:10.1016/j.isci.2020.101015
PMID:32283523
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7155208/
Abstract

MCL-1 is a well-characterized inhibitor of cell death that has also been shown to be a regulator of mitochondrial dynamics in human pluripotent stem cells. We used cardiomyocytes derived from human-induced pluripotent stem cells (hiPSC-CMs) to uncover whether MCL-1 is crucial for cardiac function and survival. Inhibition of MCL-1 by BH3 mimetics resulted in the disruption of mitochondrial morphology and dynamics as well as disorganization of the actin cytoskeleton. Interfering with MCL-1 function affects the homeostatic proximity of DRP-1 and MCL-1 at the outer mitochondrial membrane, resulting in decreased functionality of hiPSC-CMs. Cardiomyocytes display abnormal cardiac performance even after caspase inhibition, supporting a nonapoptotic activity of MCL-1 in hiPSC-CMs. BH3 mimetics targeting MCL-1 are promising anti-tumor therapeutics. Progression toward using BCL-2 family inhibitors, especially targeting MCL-1, depends on understanding its canonical function not only in preventing apoptosis but also in the maintenance of mitochondrial dynamics and function.

摘要

MCL-1是一种已被充分表征的细胞死亡抑制剂,同时也被证明是人类多能干细胞中线粒体动力学的调节因子。我们利用源自人诱导多能干细胞的心肌细胞(hiPSC-CMs)来探究MCL-1对心脏功能和存活是否至关重要。BH3模拟物对MCL-1的抑制导致线粒体形态和动力学的破坏以及肌动蛋白细胞骨架的紊乱。干扰MCL-1功能会影响线粒体外膜上DRP-1和MCL-1的稳态接近度,从而导致hiPSC-CMs功能下降。即使在抑制半胱天冬酶后,心肌细胞仍表现出异常的心脏性能,这支持了MCL-1在hiPSC-CMs中的非凋亡活性。靶向MCL-1的BH3模拟物是很有前景的抗肿瘤治疗药物。向使用BCL-2家族抑制剂(尤其是靶向MCL-1的抑制剂)迈进,取决于不仅要了解其在预防细胞凋亡方面的经典功能,还要了解其在维持线粒体动力学和功能方面的作用。

相似文献

1
MCL-1 Inhibition by Selective BH3 Mimetics Disrupts Mitochondrial Dynamics Causing Loss of Viability and Functionality of Human Cardiomyocytes.选择性BH3模拟物抑制MCL-1会破坏线粒体动力学,导致人类心肌细胞活力和功能丧失。
iScience. 2020 Apr 24;23(4):101015. doi: 10.1016/j.isci.2020.101015. Epub 2020 Mar 30.
2
Role of Mcl-1 in regulation of cell death in human induced pluripotent stem cell-derived cardiomyocytes in vitro.Mcl-1 在体外诱导多能干细胞衍生的心肌细胞细胞死亡中的调节作用。
Toxicol Appl Pharmacol. 2018 Dec 1;360:88-98. doi: 10.1016/j.taap.2018.09.041. Epub 2018 Sep 28.
3
A Non-apoptotic Function of MCL-1 in Promoting Pluripotency and Modulating Mitochondrial Dynamics in Stem Cells.MCL-1 在促进干细胞多能性和调节线粒体动力学中的非凋亡功能。
Stem Cell Reports. 2018 Mar 13;10(3):684-692. doi: 10.1016/j.stemcr.2018.01.005. Epub 2018 Feb 8.
4
BH3 mimetics induce apoptosis independent of DRP-1 in melanoma.BH3 模拟物诱导黑色素瘤细胞凋亡不依赖于 DRP-1。
Cell Death Dis. 2018 Sep 5;9(9):907. doi: 10.1038/s41419-018-0932-z.
5
Side-by-side comparison of BH3-mimetics identifies MCL-1 as a key therapeutic target in AML.BH3 模拟物的并排比较确定 MCL-1 为 AML 的关键治疗靶点。
Cell Death Dis. 2019 Dec 4;10(12):917. doi: 10.1038/s41419-019-2156-2.
6
Binding affinity of pro-apoptotic BH3 peptides for the anti-apoptotic Mcl-1 and A1 proteins: Molecular dynamics simulations of Mcl-1 and A1 in complex with six different BH3 peptides.促凋亡BH3肽与抗凋亡Mcl-1和A1蛋白的结合亲和力:Mcl-1和A1与六种不同BH3肽复合物的分子动力学模拟
J Mol Graph Model. 2017 May;73:115-128. doi: 10.1016/j.jmgm.2016.12.006. Epub 2017 Feb 9.
7
Preferential targeting of MCL-1 by a hydrocarbon-stapled BIM BH3 peptide.一种烃链稳定的BIM BH3肽对MCL-1的优先靶向作用。
Oncotarget. 2019 Oct 22;10(58):6219-6233. doi: 10.18632/oncotarget.27262.
8
The first MCL-1-selective BH3 mimetics have therapeutic potential for chronic lymphocytic leukemia.首个 MCL-1 选择性 BH3 模拟物具有治疗慢性淋巴细胞白血病的潜力。
Crit Rev Oncol Hematol. 2016 Apr;100:32-6. doi: 10.1016/j.critrevonc.2016.02.003. Epub 2016 Feb 11.
9
Predicting effective pro-apoptotic anti-leukaemic drug combinations using co-operative dynamic BH3 profiling.使用协同动态BH3分析预测有效的促凋亡抗白血病药物组合。
PLoS One. 2018 Jan 3;13(1):e0190682. doi: 10.1371/journal.pone.0190682. eCollection 2018.
10
Mechanism of synergy of BH3 mimetics and paclitaxel in chronic myeloid leukemia cells: Mcl-1 inhibition.BH3模拟物与紫杉醇在慢性粒细胞白血病细胞中的协同作用机制:Mcl-1抑制作用
Eur J Pharm Sci. 2015 Apr 5;70:64-71. doi: 10.1016/j.ejps.2015.01.003. Epub 2015 Jan 14.

引用本文的文献

1
Apoptosis-targeting BH3 mimetics: transforming treatment for patients with acute myeloid leukaemia.靶向凋亡的BH3模拟物:改变急性髓系白血病患者的治疗方式
Nat Rev Clin Oncol. 2025 Sep 1. doi: 10.1038/s41571-025-01068-0.
2
Discovery of Macrocyclic Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors that Demonstrate Potent Cellular Efficacy and In Vivo Activity in a Mouse Solid Tumor Xenograft Model.发现大环类髓样细胞白血病1(Mcl-1)抑制剂,其在小鼠实体瘤异种移植模型中展现出强大的细胞功效和体内活性。
J Med Chem. 2025 Sep 11;68(17):18553-18578. doi: 10.1021/acs.jmedchem.5c01376. Epub 2025 Aug 27.
3
Feasibility and Safety of Targeting Mitochondria Function and Metabolism in Acute Myeloid Leukemia.

本文引用的文献

1
Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine.心肌细胞成熟:知识进展及其对再生医学的影响。
Nat Rev Cardiol. 2020 Jun;17(6):341-359. doi: 10.1038/s41569-019-0331-x. Epub 2020 Feb 3.
2
Targeting HIF-1α in combination with PPARα activation and postnatal factors promotes the metabolic maturation of human induced pluripotent stem cell-derived cardiomyocytes.靶向 HIF-1α 与 PPARα 激活和出生后因素相结合可促进人诱导多能干细胞衍生心肌细胞的代谢成熟。
J Mol Cell Cardiol. 2019 Jul;132:120-135. doi: 10.1016/j.yjmcc.2019.05.003. Epub 2019 May 11.
3
Molecular Comprehension of Mcl-1: From Gene Structure to Cancer Therapy.
靶向急性髓系白血病线粒体功能和代谢的可行性与安全性
Curr Pharmacol Rep. 2024 Dec;10(6):388-404. doi: 10.1007/s40495-024-00378-8. Epub 2024 Oct 4.
4
Predictors of response to venetoclax and therapeutic potential of CDK7 inhibition in multiple myeloma.多发性骨髓瘤中维奈托克反应的预测因素及CDK7抑制的治疗潜力
Blood Neoplasia. 2024 Oct 14;1(4):100049. doi: 10.1016/j.bneo.2024.100049. eCollection 2024 Dec.
5
Copper Chelation Induces Morphology Change in Mitochondria of Triple-Negative Breast Cancer.铜螯合诱导三阴性乳腺癌线粒体形态改变。
JACS Au. 2025 Apr 25;5(5):2102-2113. doi: 10.1021/jacsau.5c00035. eCollection 2025 May 26.
6
Engineering anti-BCMA CAR T cells for enhancing myeloma killing efficacy via apoptosis regulation.通过凋亡调控工程化抗BCMA嵌合抗原受体T细胞以增强骨髓瘤杀伤效力。
Nat Commun. 2025 May 19;16(1):4638. doi: 10.1038/s41467-025-59818-8.
7
Structural basis of BAK sequestration by MCL-1 in apoptosis.MCL-1在细胞凋亡中隔离BAK的结构基础。
Mol Cell. 2025 Apr 17;85(8):1606-1623.e10. doi: 10.1016/j.molcel.2025.03.013. Epub 2025 Apr 4.
8
MCL‑1 safeguards activated hair follicle stem cells to enable adult hair regeneration.髓细胞白血病‑1(MCL‑1)保护激活的毛囊干细胞以实现成年毛发再生。
Nat Commun. 2025 Mar 22;16(1):2829. doi: 10.1038/s41467-025-58150-5.
9
Src inhibition potentiates MCL-1 antagonist activity in acute myeloid leukemia.Src抑制增强急性髓系白血病中MCL-1拮抗剂的活性。
Signal Transduct Target Ther. 2025 Feb 10;10(1):50. doi: 10.1038/s41392-025-02125-x.
10
MCL-1 regulates cellular transitions during oligodendrocyte development.MCL-1在少突胶质细胞发育过程中调节细胞转变。
bioRxiv. 2024 Dec 21:2024.12.20.629796. doi: 10.1101/2024.12.20.629796.
Mcl-1 的分子理解:从基因结构到癌症治疗。
Trends Cell Biol. 2019 Jul;29(7):549-562. doi: 10.1016/j.tcb.2019.03.004. Epub 2019 Apr 25.
4
Genetic Variants Associated With Cancer Therapy-Induced Cardiomyopathy.与癌症治疗诱导性心肌病相关的遗传变异。
Circulation. 2019 Jul 2;140(1):31-41. doi: 10.1161/CIRCULATIONAHA.118.037934. Epub 2019 Apr 16.
5
Recent advances in the development of Mcl-1 inhibitors for cancer therapy.近年来,用于癌症治疗的 Mcl-1 抑制剂的研究进展。
Pharmacol Ther. 2019 Jun;198:59-67. doi: 10.1016/j.pharmthera.2019.02.007. Epub 2019 Feb 18.
6
Current methods for the maturation of induced pluripotent stem cell-derived cardiomyocytes.诱导多能干细胞来源的心肌细胞成熟的当前方法。
World J Stem Cells. 2019 Jan 26;11(1):33-43. doi: 10.4252/wjsc.v11.i1.33.
7
Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia.Mcl-1 特异性抑制剂 AZD5991 的发现及其在多发性骨髓瘤和急性髓系白血病中的临床前活性。
Nat Commun. 2018 Dec 17;9(1):5341. doi: 10.1038/s41467-018-07551-w.
8
Hypoxia-induced interaction of filamin with Drp1 causes mitochondrial hyperfission-associated myocardial senescence.缺氧诱导细丝蛋白与 Drp1 相互作用导致与线粒体过度分裂相关的心肌衰老。
Sci Signal. 2018 Nov 13;11(556):eaat5185. doi: 10.1126/scisignal.aat5185.
9
Role of Mcl-1 in regulation of cell death in human induced pluripotent stem cell-derived cardiomyocytes in vitro.Mcl-1 在体外诱导多能干细胞衍生的心肌细胞细胞死亡中的调节作用。
Toxicol Appl Pharmacol. 2018 Dec 1;360:88-98. doi: 10.1016/j.taap.2018.09.041. Epub 2018 Sep 28.
10
AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies.AMG 176,一种选择性 MCL1 抑制剂,在单独使用和与现有疗法联合使用时对血液系统癌症模型均有效。
Cancer Discov. 2018 Dec;8(12):1582-1597. doi: 10.1158/2159-8290.CD-18-0387. Epub 2018 Sep 25.